United Therapeutics
UTHR
Performance
About United Therapeutics
United Therapeutics is a biotechnology company focused on creating unique products to address the medical needs of patients with chronic illnesses. The company develops therapies intended to improve quality of life and outcomes for patients dealing with long-term health conditions. While the specific geographical scope isn’t stated on the page, the organization presents itself as a global biotech entity dedicated to innovative medical solutions.
Recent News
STAT+: Novo Nordisk’s Less-Bad News on Its Wegovy Pill Boosts Earnings and Share Price
Enveric Biosciences Posts $1.6M Q1 Loss, Raises $16.7M as EB-003 Enters Preclinical Trials
Final Frontier for Meds? UK Startup Sends Drug-Making Into Space
First Hydrogen Helicopter Just Proved It Can Fly a Real Mission
Sixth Varda Mission Successfully Returns
Trade Secret Litigation Trends in Life Sciences
Maryland’s Biopharma Cluster Takes on Coastal Hubs
Here Are Thursday's Biggest Analyst Calls: Nvidia, Apple, Uber, Microsoft, Disney, CoreWeave, Alcoa & More
FDA Approves the First PROTAC in History, a $1B siRNA Wave Hits Cardiometabolic Disease, and Cytokinetics Cracks Non-Obstructive HCM – This Week in Biotech #99
MannKind Corp. (MNKD) Reports Q1 2026 Total Revenues of $90.2M
60 Degrees Pharmaceuticals Inc (SXTP) Q1 2026 Earnings Call Transcript
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
Recent Deals
No recent deals for this company.